Clinical Trials Browser

Astrocytoma, Carcinoma, Renal Cell, Ependymoma, Glioma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Recurrence, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Rhabdoid Tumor

NCT01791088 2019-04-22

Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Phase 1 Completed

56 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT02449564 2018-01-17

The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

Phase NA Completed

5 enrolled

Other solid neoplasm

Solid Tumor

NCT00255658 2015-04-15

Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00880282 2014-04-29

Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment

Phase 1 Completed

39 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT01141244 2014-04-10

Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

72 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00375245 2014-01-17

Rapamycin With Grapefruit Juice for Advanced Malignancies

Phase 1 Completed

41 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther solid neoplasmThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT00583063 2013-06-12

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

Phase EARLY_PHASE1 Completed

23 enrolled

Other solid neoplasm

Solid Tumors

NCT00098501 2013-06-04

CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

42 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00368914 2010-08-09

Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00509613 2009-09-18

Phase 1 Study With Sorafenib and Sirolimus

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor

Clinical Trials

COAST

AflacST1903

RAPIRI

A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

Aflac ST0901

Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors

Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment

Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Rapamycin With Grapefruit Juice for Advanced Malignancies

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors

Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Study With Sorafenib and Sirolimus